Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?

Figures & data

Table 1 Demographic and Anthropometric Features of Included Patients

Status of Steatosis	Normal	NAFLD	NAPS	NAPS+NAFLD	p**
Cases (n=345)	74(21.4%)	44(12,8%)	52(15.1%)	175(50,7%)	—
Sex (F/M)	54/20	29/15	37/15	100/75	0.661
Age (years)	41±14	44±13	56.4±15	55±13	0.000*
BMI (kg/m^2)	23±3	28±4	26±3	31±5	0.040*
BFP (%)	28±8	34±9	34±7	39±9	0.930
Diabetes mellitus	5 (6.8%)	7(15,9%)	9(17.3%)	84(36%)	1.000
Hepatomegaly	24,3%	47.7%	30.8%	70.3%	0.098
Cholecystolithiasis	6,8%	13,6%	28.8%	26.3%	0.087

Notes: *Significant (p<0.05); **Comparison between NAFLD and NAPS.

Abbreviations: NAFLD, nonalcoholic fatty liver disease; NAPS, nonalcoholic pancreatic steatosis; F, female; M, male; BMI, body mass index; BFP, body fat percentage.

Table 2 Laboratory Values of the Study Group

Status of Steatosis	Normal	NAFLD	NAPS	NAPS+NAFLD	p**
Insulin level	6.6±2.3	8.3±4.0	9.6±8.0	13.5±8.9	0.000*
Insulin resistance	1.5±0.6	1.9±0.8	3.2±5.7	3.9±3.5	0.017
ALT (IU/mL)	22±19	29±18	23±21	31±23	0.130
Triglyceride (mg/dL)	93±47	137±65	119±76	164±83	0.218
HDL-cholesterol	53±13	46±9	54±13	48±15	0.001*
Total cholesterol	189±47	205±46	202±42	207±45	0.816

Notes: *Significant (p<0.05); **Comparison between NAFLD and NAPS.

Abbreviations: NAFLD, nonalcoholic fatty liver disease; NAPS, nonalcoholic pancreatic steatosis; ALT, alanine aminotransferase.

Figure 1 Serum Triglyceride levels of subgroups.

Abbreviations: NAPS, Nonalcoholic pancreatic steatosis; NAFLD, Nonalcoholic fatty liver disease.

Figure 2 Venn diagram of NAPS and NAFLD.

Abbreviations: NAPS, Nonalcoholic pancreatic steatosis; NAFLD, Nonalcoholic fatty liver disease.

Figure 3 Receiver operating characteristic (ROC) curve for insulin resistance, triglyceride, body mass index, and age in nonalcoholic pancreatic steatosis area under the ROC curve.